Molina Healthcare (MOH) Stock Forecast & Price Target

Molina Healthcare is well positioned by its core Medicaid franchise, which serves more than 5 million members and has shown improving margin dynamics as 3Q26 delivered a solid MCR beat across Medicaid and Marketplace. Management’s commentary that rate increases are catching up to cost trend, combined with Nebraska’s more benign work-requirement rollout and the expectation that roughly 80% of its footprint may adopt similarly liberal interpretations, lowers attrition risk and supports earnings durability. The company also has clear upside from 2027 building blocks of more than $9.50 in adjusted EPS before any legacy MCR improvement, backed by about $45 billion of premium revenue and meaningful leverage from the Florida CMS win, MAPD exit, and operating leverage.

Molina Healthcare is facing a fragile fundamental setup because more than 85% of members come from Medicaid, leaving results highly exposed to state funding, rate adequacy, and policy shifts. The stock’s near-term recovery may already be reflected in its 20.6x 2027 adjusted EPS multiple, while roughly $7.25/share of the 2026-to-2029 EPS bridge depends on Medicaid rates catching up to trend, a risky assumption as OBBBA cuts, work requirements, and redeterminations pressure enrollment and reimbursement. With four major Medicaid states—California, New York, Texas, and Washington—accounting for over half of enrollees, any contract loss or slower-than-expected margin recovery could materially undermine the path to 2029 earnings.